Table 1.

Main characteristics of the patients with skin lesions

Case n.	M/F	Age (years)	Pneumonia	Days from the onset of COVID symptoms	Positive NPh * swab	COVID therapy	Site of cutaneous lesions	Days to resolution
1	f	29	No	3	No	No	Acral lesions associated to erythema-oedema and pain, on toes and fingers	14
2	m	19	No	13	No	No	Red-purple pinpricks and cyanotic lesions of toes	7
3**	m	15	No	No symptoms	No	No	Plantar surface painful papules; Erythemato-cyanotic bullous lesions of toes	>14
4	m	18	No	21	No	No	Chilblain-like lesions of the toes Histology available	14
5	f	52	Yes	7	Yes	Remdesivir	Erythematous rash on the whole body	3
6	m	59	Yes	8	Yes	Hydroxychloroquine plus azithromycin	Multiple purpuric and erythematous lesions on the trunk and legs	7
7	m	65	Yes	3	Yes	Hydroxychloroquine plus azithromycin	Purpuric confluent rash in the area of calf muscle	3
8	f	30	No	4	Yes	No	Erythematous papular-pustular rash on the trunk	7

*NPh = nasopharyngeal.

**Case 3 was negative at NPh swab and serology. See text for explanation.